Incordex EBIT

The latest EBIT for ICDX is $-8.8K as of March 2025. That is below the sector sector average of $2.5T. Investors often review this figure alongside Incordex's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, ICDX currently prints $-8.8K for EBIT, while the sector average sits near $2.5T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Incordex's growth, margins, and balance sheet.

A EBIT figure of $-8.8K for ICDX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting ICDX's EBIT ($-8.8K), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.